This review highlights sessions from ESCMID Global 2024 on the role of global virus surveillance and early detection of novel viruses, and study design for high-quality data to assess vaccine impact for respiratory viruses like influenza, SARS-CoV-2, and RSV.
In this issue
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.